SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-000100
Filing Date
2019-01-02
Accepted
2019-01-02 17:02:07
Documents
2
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 13224
2 EXHIBIT LIST - EXHIBIT 24.1 - POWER OF ATTORNEY poa_nanda.htm EX-24.1 6644
  Complete submission text file 0001567619-19-000100.txt   21177
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Issuer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 281 TRESSER BOULEVARD STAMFORD CT 06901
Business Address
Nanda Nisha (Reporting) CIK: 0001762683 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36562 | Film No.: 19502437